May 14, 2019
Chugai Pharmaceutical’s cancer drug Avastin (bevacizumab) was the best-selling drug in Japan in April with 11.5 billion yen on an NHI price basis, according to a monthly snapshot report released by market research firm Encise. Avastin was closely trailed by...read more